6771 - 6780 of 8654 Results
Title
Year
- No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease2019OPENTitle: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 87Issue #:Start Page: 140.e19End Page: 140.e22Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0197458019303951Citation Count: 13
- A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease2025OPENTitle: A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 31Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41591-025-03565-2Best OA location URL: https://www.nature.com/articles/s41591-025-03565-2.pdfCitation Count: 19
- The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized Seizures2013OPENTitle: The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized SeizuresJournal Name: Human MutationPublisher: Hindawi LimitedVol: 34Issue #: 9Start Page: 1200End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oa, unspecified-oaDOI - Digital Object Identifier: 10.1002/humu.22372Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/humu.22372Citation Count: 315
- Measuring Up: A Comparison of TapeStation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain Samples2023OPENTitle: Measuring Up: A Comparison of TapeStation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain SamplesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 18Start Page: 13795End Page: 13795Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241813795Best OA location URL: https://www.mdpi.com/1422-0067/24/18/13795/pdf?version=1694073777Citation Count: 10
- 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice2014RESTRICTEDTitle: 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated miceJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 92Issue #:Start Page: 86End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2014.11.005Citation Count: 59
- Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain2018OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 43
- In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker2023OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 4
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 34
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022OPENTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Best OA location URL: https://psyarxiv.com/zvqge/downloadCitation Count: 5
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5797696Citation Count: 58